VO

Vincent Ossipow

Partner at Omega Funds

Geneva, Geneva

Invests in

Locations:

  • Min Investment:

    $100,000.00
  • Max Investment:

    $5,000,000.00
  • Target Investment:

    $1,500,000.00

Work Experience

  • Partner

    2014

  • Partner at Omega Funds

    2014

  • Partner

    2014 - 2017

  • Chief Scientific Officer (CSO)

    2021

  • Member of the Board of Directors

    2007

    Current Board Seats: -Aerium Therapeutics (USA-Switzerland, private), Board Director -Immunic (USA, NASDAQ listed), Board Director, Chairman of the Nomination Committee, prior member of the Audit Committee, prior member of the Remuneration Committee -Bioinvent (Sweden, publicly listed), Board Director, member of the Nomination Committee, prior member of the Audit Committee -Sophia Genetics (Switzerland, NASDAQ listed), Independent Board Director, member of the Remuneration Committee -Etherna Immuno-Oncology (Belgium, private), Chairman of the Audit Committee, Board Director -FoRx (Switzerland, private), Board Director, member of the Nomination Committee -Anaconda Brain (Spain, private), Board observer Prior Board of Director experience: -Andrew Alliance (Switzerland, private), Board Director, member of the Remuneration Committee. Acquired -LifeSpan (USA, private), Board Director. Acquired -Raindance Technologies (USA, private), Board Director. Acquired -Kuros Biosciences (Switzerland, publicly traded), Board Director, Chairman of the Audit Committee -Endosense (Switzerland, private), Board observer. Acquired

  • Partner Private Equity

    2012 - 2013

  • Investment Manager

    2007 - 2012

  • Faculty Member

    2000 - 2007

  • Financial Analyst

    1998 - 2000

  • Postdoctoral Fellow

    1997 - 1998